Jeffrey G. Spragens - Feb 28, 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Jeffrey G. Spragens
Stock symbol
SABS
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 08:20 AM
Previous filing
Dec 9, 2022
Next filing
Jul 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Warrants Other $0 +19.9K $0.00 19.9K Feb 28, 2023 Common Stock 19.9K $11.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a member of Big Cypress Holdings LLC, and as part of the distribution received 19,936 warrants of the issuer.